Cargando…
FIR haplodeficiency promotes splicing to pyruvate kinase M2 in mice thymic lymphoma tissues revealed by six-plex tandem mass tag quantitative proteomic analysis
The switch of pyruvate kinase (PK) M1 to PKM2 is pivotal for glucose metabolism in cancers. The PKM1/M2 shift is controlled by the alternative splicing of two mutually exclusive exons in the PKM gene. PKM1 is expressed in differentiated tissues, whereas PKM2 is expressed in cancer tissues. This stud...
Autores principales: | Kimura, Asako, Kitamura, Kouichi, Ailiken, Guzhanuer, Satoh, Mamoru, Minamoto, Toshinari, Tanaka, Nobuko, Nomura, Fumio, Matsushita, Kazuyuki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5620227/ https://www.ncbi.nlm.nih.gov/pubmed/28978087 http://dx.doi.org/10.18632/oncotarget.19061 |
Ejemplares similares
-
Post-transcriptional regulation of BRG1 by FIRΔexon2 in gastric cancer
por: Ailiken, Guzhanuer, et al.
Publicado: (2020) -
Disturbed alternative splicing of FIR (PUF60) directed cyclin E overexpression in esophageal cancers
por: Ogura, Yukiko, et al.
Publicado: (2018) -
Anti‐FIRΔexon2, a splicing variant form of PUF60, autoantibody is detected in the sera of esophageal squamous cell carcinoma
por: Kobayashi, Sohei, et al.
Publicado: (2019) -
Anti-FIRs (PUF60) auto-antibodies are detected in the sera of early-stage colon cancer patients
por: Kobayashi, Sohei, et al.
Publicado: (2016) -
Haploinsufficiency of the c-myc transcriptional repressor FIR, as a dominant negative-alternative splicing model, promoted p53-dependent T-cell acute lymphoblastic leukemia progression by activating Notch1
por: Matsushita, Kazuyuki, et al.
Publicado: (2014)